FrancophonIA/ELRC3.0 huggingface dataset:
English: In a single-dose study healthy volunteers received 20 mg/day and in a ten-day study healthy volunteers received 10 mg/day.
Norwegian Bokmål: Overdose kan være forbundet med signifikant hemming av både MAO-A og MAO-B. I en enkeltdose-studie fikk friske frivillige 20 mg/dag og i en 10-dagers studie fikk friske frivillige 10 mg/dag.
English: Experimental data indicated that rasagiline inhibits prolactin secretion and thus, may inhibit lactation.
Norwegian Bokmål: Eksperimentelle data indikerer at rasagilin hemmer prolaktinsekresjon og derfor kan hemme melkeproduksjonen.
English: Uncommon: angina pectoris (0.5% vs. 0%)
Norwegian Bokmål: Mindre vanlige: angina pectoris (0.5% vs. 0%)
English: Caution should be used when initiating treatment with rasagiline in patients with mild hepatic impairment.
Norwegian Bokmål: Forsiktighet bør utvises når en starter behandling med rasagilin hos pasienter med lett nedsatt leverfunksjon.
English: • runny nose (rhinitis)
Norwegian Bokmål: • rennende nese (rinitt)
English: Common: depression (5.4% vs. 2%), hallucinations (1.3% vs. 0.7%) Nervous system disorders
Norwegian Bokmål: Vanlige: depresjon (5.4% vs. 2%), hallusinasjoner (1.3% vs. 0.7%) Nevrologiske sykdommer
English: In study II, the mean difference in the number of hours spent in the “OFF” state compared to placebo was -0.78h, 95% CI [-1.18, -0.39], p=0.0001.
Norwegian Bokmål: I studie II var gjennomsnittlig timer i ”OFF”-fasen sammenlignet med placebo -0.78 timer, 95% KI [-1,18, -0,39], p=0.0001.
English: Severe hepatic impairment.
Norwegian Bokmål: Alvorlig nedsatt leverfunksjon.
English: - pethidine (a strong pain killer).
Norwegian Bokmål: petidin (et sterkt smertestillende middel)
English: What you need to know before you take Rasagiline Mylan
Norwegian Bokmål: Hva du må vite før du bruker Rasagiline Mylan
English: Rasagiline may be taken with or without food.
Norwegian Bokmål: Rasagilin kan tas med eller uten mat.
English: • abnormal movements (dyskinesia)
Norwegian Bokmål: • ufrivillige bevegelser (dyskinesier)
English: In study II, patients were randomly assigned to receive placebo (229 patients), or rasagiline 1 mg/day (231 patients) or the catechol-O-methyl transferase (COMT) inhibitor, entacapone, 200 mg taken along with scheduled doses of levodopa (LD)/decarboxylase inhibitor (227 patients), and were treated for 18 weeks.
Norwegian Bokmål: I studie II ble pasientene randomisert utvalgt til å motta placebo (229 pasienter), rasagilin 1 mg/dag (231 pasienter) eller katekol-O-metyltransferase-hemmeren (COMT-hemmeren) entakapon 200 mg sammen med levodopa (LD)/ dekarboksylasehemmer (227 pasienter), og behandlet i 18 uker.
English: The list below includes adverse reactions which were reported with a higher incidence in placebo controlled studies, in patients receiving 1 mg/day rasagiline (rasagiline group n=149, placebo group n=151).
Norwegian Bokmål: Listen under inkluderer bivirkninger som er rapportert med en høyere frekvens i placebo-kontrollerte studier hos pasienter som fikk rasagilin 1 mg/dag (rasagilingruppen n= 149, placebogruppen n= 151).
English: In study III, patients were randomly assigned to receive placebo (159 patients), rasagiline 0.5 mg/day (164 patients), or rasagiline 1 mg/day (149 patients), and were treated for 26 weeks.
Norwegian Bokmål: I studie III ble pasientene randomisert utvalgt til å motta placebo (159 pasienter), rasagilin 0,5 mg/dag (164 pasienter) eller rasagilin 1 mg/dag (149 pasienter) og behandlet i 26 uker.
English: • prolonged muscle contractions (dystonia)
Norwegian Bokmål: • ufrivillig muskelaktivitet (dystoni)
English: Common: influenza (4.7% vs. 0.7%)
Norwegian Bokmål: Vanlige: influensa (4.7% vs. 0.7%)
English: Therefore, in view of the MAO inhibitory activity of rasagiline, antidepressants should be administered with caution.
Norwegian Bokmål: Fordi rasagilin har slik MAO-hemmende effekt bør antidepressiva gis med forsiktighet.
English: Common: hallucinations (2.9% vs. 2.1%), abnormal dreams (2.1% vs. 0.8%) Uncommon: confusion (0.8% vs. 0.5%)
Norwegian Bokmål: Vanlige: hallusinasjoner (2.9% vs. 2.1%), unormale drømmer (2.1% vs. 0.8%) Mindre vanlige: forvirring (0.8% vs. 0.5%) Nevrologiske sykdommer
English: The concomitant use of rasagiline and dextromethorphan or sympathomimetics such as those present in nasal and oral decongestants or cold medicinal product containing ephedrine or pseudoephedrine is not recommended (see section 4.5).
Norwegian Bokmål: Samtidig bruk av rasagilin og dekstrometorfan eller sympatomimetika som finnes i nasale og orale slimhinneavsvellende midler eller forkjølelsesmidler som inneholder efedrin eller pseudoefedrin, anbefales ikke (se punkt 4.5).
English: Caution should be exercised when rasagiline is administered to a breast-feeding mother.
Norwegian Bokmål: Forsiktighet anbefales når rasagilin gis til ammende mødre.
English: If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking any medicine.
Norwegian Bokmål: Rådfør deg med lege eller apotek før du tar dette legemidlet dersom du er gravid eller ammer, tror at du kan være gravid eller planlegger å bli gravid.
English: EU/1/16/1090/001 (7 tablets - oPA/alu/PVC/alu) EU/1/16/1090/002 (10 tablets - oPA/alu/PVC/alu) EU/1/16/1090/003 (28 tablets - oPA/alu/PVC/alu) EU/1/16/1090/004 (30 tablets - oPA/alu/PVC/alu) EU/1/16/1090/005 (100 tablets - oPA/alu/PVC/alu) EU/1/16/1090/006 (112 tablets - oPA/alu/PVC/alu) EU/1/16/1090/007 (7 tablets - PVC/PVDC/alu) EU/1/16/1090/008 (10 tablets - PVC/PVDC/alu) EU/1/16/1090/009 (28 tablets - PVC/PVDC/alu) EU/1/16/1090/010 (30 tablets - PVC/PVDC/alu) EU/1/16/1090/011 (100 tablets - PVC/PVDC/alu) EU/1/16/1090/012 (112 tablets - PVC/PVDC/alu) EU/1/16/1090/013 (7 x 1 tablets - PVC/PVDC/alu) EU/1/16/1090/014 (10 x 1 tablets - PVC/PVDC/alu) EU/1/16/1090/015 (28 x 1 tablets - PVC/PVDC/alu) EU/1/16/1090/016 (30 x 1 tablets - PVC/PVDC/alu) EU/1/16/1090/017 (100 x 1 tablets - PVC/PVDC/alu) EU/1/16/1090/018 (112 x 1 tablets - PVC/PVDC/alu)
Norwegian Bokmål: EU/1/16/1090/001 (7 tabletter - oPA/alu/PVC/alu) EU/1/16/1090/002 (10 tabletter - oPA/alu/PVC/alu) EU/1/16/1090/003 (28 tabletter - oPA/alu/PVC/alu) EU/1/16/1090/004 (30 tabletter - oPA/alu/PVC/alu) EU/1/16/1090/005 (100 tabletter - oPA/alu/PVC/alu) EU/1/16/1090/006 (112 tabletter - oPA/alu/PVC/alu) EU/1/16/1090/007 (7 tabletter - PVC/PVDC/alu) EU/1/16/1090/008 (10 tabletter - PVC/PVDC/alu) EU/1/16/1090/009 (28 tabletter - PVC/PVDC/alu) EU/1/16/1090/010 (30 tabletter - PVC/PVDC/alu) EU/1/16/1090/011 (100 tabletter - PVC/PVDC/alu) EU/1/16/1090/012 (112 tabletter - PVC/PVDC/alu) EU/1/16/1090/013 (7×1 tabletter - PVC/PVDC/alu) EU/1/16/1090/014 (10×1 tabletter - PVC/PVDC/alu) EU/1/16/1090/015 (28×1 tabletter - PVC/PVDC/alu) EU/1/16/1090/016 (30×1 tabletter - PVC/PVDC/alu) EU/1/16/1090/017 (100×1 tabletter - PVC/PVDC/alu) EU/1/16/1090/018 (112×1 tabletter - PVC/PVDC/alu)
English: Uncommon: cerebrovascular accident (0.5% vs. 0.3%) Cardiac disorders
Norwegian Bokmål: Mindre vanlige: cerebrovaskulær hendelse (0.5% vs. 0.3%) Hjertesykdommer
English: Certain antidepressants (selective serotonin reuptake inhibitors, selective serotonin-norepinephrine reuptake inhibitors, tricyclic or tetracyclic antidepressants) the antibiotic ciprofloxacin used against infections the cough suppressant dextromethorphan sympathomimetics such as those present in eye drops, nasal and oral decongestants and cold medicine containing ephedrine or pseudoephedrine
Norwegian Bokmål: Rådfør deg med lege før du tar noen av følgende legemidler sammen med Rasagiline Mylan: Visse midler mot depresjon (selektive serotoninreopptakshemmere, selektive serotoninnoradrenalinreopptakshemmere, trisykliske eller tetrasykliske antidepressiva), ciprofloksacin (antibiotikum brukes mot infeksjoner) dekstrometorfan (hostestillende) spesielle stoffer (sympatomimetika) som finnes i øyedråper, slimhinneavsvellende midler og forkjølelsesmidler som inneholder efedrin eller pseudoefedrin.
English: General disorders and administration site conditions Common: fever (2.7% vs. 1.3%), malaise (2% vs. 0%)
Norwegian Bokmål: Generelle lidelser og reaksjoner på administrasjonsstedet Vanlige: feber (2.7% vs. 1.3%), ubehag (2% vs. 0%).
English: Concomitant treatment with other monoamine oxidase (MAO) inhibitors (including medicinal and natural products without prescription e.g. St. John's Wort) or pethidine (see section 4.5).
Norwegian Bokmål: Samtidig behandling med andre monoaminoksidasehemmere (MAO-hemmere) (inkludert reseptfrie legemidler og naturmidler, for eksempel Johannesurt) eller petidin (se punkt 4.5).
English: Similar reports of ICDs have also been received post-marketing with rasagiline.
Norwegian Bokmål: Lignende rapporter om impulskontrollforstyrrelser er også rapportert etter markedsføring av rasagilin.
English: Common: dystonia (2.4% vs. 0.8%), carpal tunnel syndrome (1.3% vs. 0%), balance disorder (1.6% vs. 0.3%)
Norwegian Bokmål: Vanlige: dystoni (2.4% vs. 0.8%), karpaltunnelsyndrom (1.3% vs. 0%), balanseforstyrrelse (1.6% vs. 0.3%)
English: The tablets are available in blister packs of 7, 10, 28, 30, 100 and 112 tablets and in perforated blister packs containing 7 x 1, 10 x 1, 28 x 1, 30 x 1, 100 x 1 and 112 x 1 tablets.
Norwegian Bokmål: Tablettene selges i blisterpakninger med 7, 10, 28, 30, 100 eller 112 tabletter eller i perforerte blisterpakninger med 7×1, 10×1, 28×1, 30×1, 100×1 eller 112×1 tabletter.
English: The concomitant use of rasagiline and fluoxetine or fluvoxamine should be avoided (see section 4.4).
Norwegian Bokmål: Samtidig bruk av rasagilin og fluoksetin eller fluvoksamin bør unngås (se punkt 4.4).
English: Common: allergy (1.3% vs. 0.7%)
Norwegian Bokmål: Vanlige: allergi (1.3% vs. 0.7%)
English: Hypersensitivity to the active substance or to any of the excipients (listed in section 6.1).
Norwegian Bokmål: Overfølsomhet overfor virkestoffet eller overfor noen av hjelpestoffene (listet opp i pkt.
English: Do not stop taking Rasagiline Mylan without first talking to your doctor.
Norwegian Bokmål: Dersom du avbryter behandling med Rasagiline Mylan Du må ikke slutte med Rasagiline Mylan før du har diskutert det med lege.
English: Serious adverse reactions have been reported with the concomitant use of SSRIs, SNRIs, tricyclic/tetracyclic antidepressants and MAO inhibitors.
Norwegian Bokmål: Alvorlige bivirkninger er rapportert ved samtidig bruk av SSRI, SNRI, trisykliske/tetrasykliske antidepressiva og MAO-hemmere.
English: Rasagiline use in patients with moderate hepatic impairment should be avoided.
Norwegian Bokmål: Rasagilin bør unngås hos pasienter med moderat nedsatt leverfunksjon.
English: The concomitant use of rasagiline and fluoxetine or fluvoxamine should be avoided (see section 4.5).
Norwegian Bokmål: Samtidig bruk av rasagilin og fluoksetin eller fluvoksamin bør unngås (se punkt 4.5).
English: Rasagiline use in patients with severe hepatic impairment is contraindicated (see section 4.3).
Norwegian Bokmål: Rasagilin er kontraindisert hos pasienter med alvorlig nedsatt leverfunksjon (se punkt 4.3).
English: Other medicines and Rasagiline Mylan
Norwegian Bokmål: Andre legemidler og Rasagiline Mylan
English: In a dose escalation study in patients on chronic levodopa therapy treated with 10 mg/day of rasagiline, there were reports of cardiovascular undesirable reactions (including hypertension and postural hypotension) which resolved following treatment discontinuation.
Norwegian Bokmål: I en dosefinnende studie av pasienter på kronisk levodopabehandling som ble behandlet med rasagilin 10 mg/dag, er det rapportert uønskede hjerte-karreaksjoner (inkl.
English: In case patients progress from mild to moderate hepatic impairment rasagiline should be stopped (see section 4.4).
Norwegian Bokmål: Hvis pasientens tilstand forverres fra mild til moderat nedsatt leverfunksjon bør rasagilinbehandling avsluttes (se punkt 4.4)
English: Do not take the following medicines while taking Rasagaline Mylan: - monoamine oxidase (MAO) inhibitors (e.g. for treatment of depression or Parkinson's disease,
Norwegian Bokmål: Bruk ikke følgende legemidler samtidig med Rasagiline Mylan: monoaminoksidase (MAO) hemmere (brukes ved behandling av depresjon eller Parkinsons sykdom, eller for andre sykdommer), inkludert reseptfrie legemidler eller naturmidler, for eksempel Johannesurt.
English: At least five weeks should elapse between discontinuation of fluoxetine and initiation of treatment with rasagiline.
Norwegian Bokmål: Det bør gå minst 5 uker fra seponering av fluoksetin og til behandling med rasagilin påbegynnes.
English: Serious adverse reactions are known to occur with the concomitant use of SSRIs, SNRIs, tricyclic/tetracyclic antidepressants and MAO inhibitors.
Norwegian Bokmål: Det er kjent at alvorlige bivirkninger oppstår ved samtidig bruk av SSRI, SNRI, trisykliske/ tetrasykliske antidepressiva og MAO-hemmere.
English: The concomitant administration of rasagiline and pethidine is contraindicated (see section 4.3).
Norwegian Bokmål: Samtidig bruk av rasagilin og petidin er kontraindisert (se punkt 4.3)
English: Common: conjunctivitis (2.7% vs. 0.7%)
Norwegian Bokmål: Vanlige: konjunktivitt (2.7% vs. 0.7%)
English: Common: orthostatic hypotension (3.9% vs. 0.8%) Gastrointestinal disorders
Norwegian Bokmål: Vanlige: ortostatisk hypotensjon (3.9% vs. 0.8%)
English: If you forget to take Rasagiline Mylan
Norwegian Bokmål: Dersom du har glemt å ta Rasagiline Mylan
English: Adverse reactions with at least 2% difference over placebo are marked in italics.
Norwegian Bokmål: Bivirkninger med minst 2 % høyere frekvens enn placebo er angitt i kursiv.
English: • Very common (may affect more than 1 in 10 people)
Norwegian Bokmål: • Svært vanlige (kan berøre flere enn 1 av 10 personer)
English: In case patients progress from mild to moderate hepatic impairment, rasagiline should be stopped (see section
Norwegian Bokmål: Hvis pasientens tilstand forverres fra mild til moderat nedsatt leverfunksjon bør rasagilinbehandling avsluttes (se punkt 5.2).
English: Synthon Hispania S.L., C/ Castelló no1, Pol. Las Salinas, 08830, Sant Boi de Llobregat, Barcelona, Spain
Norwegian Bokmål: 08830, Sant Boi de Llobregat, Barcelona, Spania
English: At least 14 days should elapse between discontinuation of rasagiline and initiation of treatment with fluoxetine or fluvoxamine.
Norwegian Bokmål: Det bør gå minst 14 dager mellom seponering av rasagilin og til behandling med fluoksetin eller fluvoksamin påbegynnes.
English: Common: abdominal pain (4.2% vs. 1.3%), constipation (4.2% vs. 2.1%), nausea and vomiting (8.4% vs. 6.2%), dry mouth (3.4% vs. 1.8%)
Norwegian Bokmål: Vanlige: buksmerter (4.2% vs. 1.3%), forstoppelse (4.2% vs. 2.1%), kvalme og oppkast (8.4% vs.
English: EU/1/16/1090/001 (7 tablets - oPA/alu/PVC/alu) EU/1/16/1090/002 (10 tablets - oPA/alu/PVC/alu) EU/1/16/1090/003 (28 tablets - oPA/alu/PVC/alu) EU/1/16/1090/004 (30 tablets - oPA/alu/PVC/alu) EU/1/16/1090/005 (100 tablets - oPA/alu/PVC/alu) EU/1/16/1090/006 (112 tablets - oPA/alu/PVC/alu) EU/1/16/1090/007 (7 tablets - PVC/PVDC/alu) EU/1/16/1090/008 (10 tablets - PVC/PVDC/alu) EU/1/16/1090/009 (28 tablets - PVC/PVDC/alu) EU/1/16/1090/010 (30 tablets - PVC/PVDC/alu) EU/1/16/1090/011 (100 tablets - PVC/PVDC/alu) EU/1/16/1090/012 (112 tablets - PVC/PVDC/alu) EU/1/16/1090/013 (7 tablets - PVC/PVDC/alu) EU/1/16/1090/014 (10 tablets - PVC/PVDC/alu) EU/1/16/1090/015 (28 tablets - PVC/PVDC/alu) EU/1/16/1090/016 (30 tablets - PVC/PVDC/alu) EU/1/16/1090/017 (100 tablets - PVC/PVDC/alu) EU/1/16/1090/018 (112 tablets - PVC/PVDC/alu)
Norwegian Bokmål: EU/1/16/1090/001 (7 tabletter - oPA/alu/PVC/alu) EU/1/16/1090/002 (10 tabletter - oPA/alu/PVC/alu) EU/1/16/1090/003 (28 tabletter - oPA/alu/PVC/alu) EU/1/16/1090/004 (30 tabletter - oPA/alu/PVC/alu) EU/1/16/1090/005 (100 tabletter - oPA/alu/PVC/alu) EU/1/16/1090/006 (112 tabletter - oPA/alu/PVC/alu) EU/1/16/1090/007 (7 tabletter - PVC/PVDC/alu) EU/1/16/1090/008 (10 tabletter - PVC/PVDC/alu) EU/1/16/1090/009 (28 tabletter - PVC/PVDC/alu)
English: Renal impairment: Rasagiline's pharmacokinetics characteristics in subjects with mild (CLcr 50-80 ml/min) and moderate (CLcr 30-49 ml/min) renal impairment were similar to healthy subjects.
Norwegian Bokmål: Nedsatt nyrefunksjon: Farmakokinetikken hos pasienter med mild (CLcr 50-80 ml/min.)
English: Therefore, in view of the MAO inhibitory activity of rasagiline, concomitant administration of rasagiline and sympathomimetics such as those present in nasal and oral decongestants or cold medicinal products, containing ephedrine or pseudoephedrine, is not recommended (see section 4.4).
Norwegian Bokmål: Fordi rasagilin har MAO-hemmende effekt, anbefales ikke samtidig bruk av rasagilin og sympatomimetika som finnes i nasale og orale slimhinneavsvellende midler eller forkjølelsesmidler som inneholder efedrin eller pseudoefedrin (se punkt 4.4).
English: Therefore, in view of the MAO inhibitory activity of rasagiline, the concomitant administration of rasagiline and dextromethorphan is not recommended (see section 4.4).
Norwegian Bokmål: Fordi rasagilin har MAO-hemmende effekt anbefales ikke samtidig bruk med dekstrometorfan (se punkt 4.4).
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without prescription or if you are smoking or intend to stop smoking.
Norwegian Bokmål: Rådfør deg med lege eller apotek dersom du bruker, nylig har brukt eller planlegger å bruke andre legemidler.
English: Rasagiline Mylan 1 mg tablets rasagiline
Norwegian Bokmål: Rasagiline Mylan 1 mg tabletter rasagilin
English: With MAO inhibitors, there have been reports of drug interactions with the concomitant use of sympathomimetic medicinal products.
Norwegian Bokmål: Det er rapportert interaksjoner med MAO-hemmere ved samtidig bruk av sympatomimetika.
English: • Rare (may affect up to 1 in 1,000 people)
Norwegian Bokmål: • Sjeldne (kan berøre opptil 1 av 1000 personer)
English: Musculoskeletal and connective tissue disorders Common: arthralgia (2.4% vs. 2.1%), neck pain (1.3% vs. 0.5%)
Norwegian Bokmål: Sykdommer i muskler, bindevev og skjelett Vanlige: artralgi (2.4% vs. 2.1%), nakkesmerter (1.3% vs. 0.5%) Undersøkelser
English: The robustness of the results for the primary efficacy end point, was confirmed in a battery of additional statistical models and was demonstrated in three cohorts (ITT, per protocol and completers).
Norwegian Bokmål: Robustheten av resultatene på primært endepunkt er bekreftet i flere statistiske modeller, og var vist i tre grupper (ITT, per protokoll og de som fullførte studien) De sekundære endepunktene inkluderte utprøvers globale vurdering av bedring, ADL (Activities of Daily Living) subskalascore i ”OFF”-fasen og UPDRS for motorisk funksjonsevne i ”ON-”fasen.
English: The mean volume of distribution following a single intravenous dose of rasagiline is 243 l.
Norwegian Bokmål: dose av rasagilin er 243 liter.
English: • Very rare (may affect up to 1 in 10,000 people)
Norwegian Bokmål: • Svært sjeldne (kan berøre opptil 1 av 10 000 personer)
English: At least 14 days must elapse between discontinuation of rasagiline and initiation of treatment with MAO inhibitors or pethidine.
Norwegian Bokmål: Det må gå minst 14 dager mellom seponering av rasagilin og til behandling med MAO-hemmere eller petidin påbegynnes.
English: In study I, 404 patients were randomly assigned to receive placebo (138 patients), rasagiline 1 mg/day (134 patients) or rasagiline 2 mg/day (132 patients) and were treated for 26 weeks, there was no active comparator.
Norwegian Bokmål: I studie I ble 404 pasienter randomisert utvalgt til å motta placebo (138 pasienter), rasagilin 1 mg/dag (134 pasienter) eller rasagilin 2 mg/dag (132 pasienter).
English: In vitro metabolism studies have indicated that cytochrome P450 1A2 (CYP1A2) is the major enzyme responsible for the metabolism of rasagiline.
Norwegian Bokmål: Metabolismestudier in vitro har antydet at rasagilin hovedsakelig metaboliseres via cytokrom P450 1A2 (CYP1A2).
English: Characteristics in patients
Norwegian Bokmål: Pasientkarakteristikker
English: A. MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE Name and address of the manufacturer(s) responsible for batch release
Norwegian Bokmål: Navn og adresse til tilvirker(e) ansvarlig for batch release
English: • musculoskeletal pain
Norwegian Bokmål: • muskel-/skjelettsmerter
English: Common: vertigo (2.7% vs. 1.3%)
Norwegian Bokmål: Vanlige: vertigo (2.7% vs. 1.3%) Hjertesykdommer
English: Common: decreased weight (4.5% vs. 1.5%) Injury, poisoning and procedural complications Common: fall (4.7% vs. 3.4%)
Norwegian Bokmål: Skader, forgiftninger og komplikasjoner ved medisinske prosedyrer Vanlige: fall (4.7% vs. 3.4%)
English: You must wait at least 14 days after stopping Rasagiline Mylan treatment and starting treatment with MAO inhibitors or pethidine.
Norwegian Bokmål: Du må vente minst 14 dager fra du slutter med Rasagiline Mylan til du starter med MAO-hemmere og petidin.
English: Infections and infestations
Norwegian Bokmål: Infeksiøse og parasittære sykdommer:
English: The mean total daily decrease in the OFF time was similar in the entacapone group (-0.80h, 95% CI [-1.20, -0.41], p<0.0001) to that observed in the rasagiline 1 mg group.
Norwegian Bokmål: Gjennomsnittlig daglig reduksjon i ”OFF”-tid var tilsvarende i entakapongruppen (-0.80 timer, 95% KI [-1,20, -0,41], p<0.0001) sammenlignet med rasagilin 1 mg. I studie III var gjennomsnittlig forskjell sammenliknet med placebo -0,94 timer, 95% KI [-1,36,0,51], p<0.0001.
English: Rasagiline Mylan
Norwegian Bokmål: Sammensetning av Rasagiline Mylan
English: There is no specific antidote.
Norwegian Bokmål: Det var ingen aktiv komparator.
English: Rasagiline Mylan1 mg tablets rasagiline
Norwegian Bokmål: Rasagilin Mylan 1 mg tabletter rasagilin
English: Uncommon: myocardial infarction (0.7% vs. 0%) Respiratory, thoracic and mediastinal disorders Common: rhinitis (3.4% vs. 0.7%)
Norwegian Bokmål: Mindre vanlige: hjerteinfarkt (0.7% vs. 0%) Sykdommer i respirasjonsorganer, thorax og mediastinum
English: Musculoskeletal and connective tissue disorders Common: musculoskeletal pain (6.7% vs. 2.6%), neck pain (2.7% vs. 0%), arthritis (1.3% vs.0.7%) Renal and urinary disorders
Norwegian Bokmål: Vanlige: muskel- og skjelettsmerter (6.7% vs. 2.6%), nakkesmerter (2.7% vs. 0%), artritt (1.3% vs.
English: The recommended dose is 1 tablet of 1 mg taken by mouth once daily.
Norwegian Bokmål: Den vanlige dosen av Rasagiline Mylan er en tablett 1 mg en gang daglig.
English: How to store Rasagiline Mylan
Norwegian Bokmål: Hvordan du oppbevarer Rasagiline Mylan
English: Rasagiline Mylan 1 mg tablets
Norwegian Bokmål: LEGEMIDLETS NAVN RASAGILINE MYLAN 1 mg tabletter
English: Very common: headache (14.1% vs. 11.9%) Uncommon: cerebrovascular accident (0.7% vs. 0%)
Norwegian Bokmål: Svært vanlige:, hodepine (14.1% vs. 11.9%)
English: Posology
Norwegian Bokmål: Tilleggsterapi
English: • irritation of the skin (dermatitis)
Norwegian Bokmål: • hudirritasjon (dermatitt)
English: How to take Rasagiline Mylan
Norwegian Bokmål: Hvordan du bruker Rasagiline Mylan
English: Take the Rasagiline Mylan carton with you to show the doctor or pharmacist.
Norwegian Bokmål: Bruk alltid Rasagiline Mylan slik legen din har fortalt deg. Kontakt lege eller apotek hvis du er usikker.
English: Neoplasms benign, malignant and unspecified (including cysts and polyps) Uncommon: skin melanoma (0.5% vs. 0.3%)
Norwegian Bokmål: Godartede, ondartede og uspesifiserte svulster (inkludert cyster og polypper) Vanlige: hudkreft (1.3% vs. 0.7%)
English: Uncommon: decreased appetite (0.7% vs. 0%) Psychiatric disorders
Norwegian Bokmål: Stoffskifte og ernæringsbetingede sykdommer Mindre vanlige: redusert appetitt (0.7% vs. 0%) Psykiatriske lidelser
English: • blistering rash (vesiculobullous rash)
Norwegian Bokmål: • leddsmerter (artralgi)
English: 2D barcode carrying the unique identifier included.
Norwegian Bokmål: SIKKERHETSANORDNING (UNIK IDENTITET) - TODIMENSJONAL STREKKODE Todimensjonal strekkode, inkludert unik identitet 18.
English: • Common (may affect up to 1 in 10 people)
Norwegian Bokmål: • Vanlige (kan berøre 1 av 10 personer)